"10.1371_journal.ppat.1000933","plos pathogens","2010-05-27T00:00:00Z","Natalia A Ilyushina; Jon P Seiler; Jerold E Rehg; Robert G Webster; Elena A Govorkova","Division of Virology, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America; Laboratory of Virus Physiology, The D.I. Ivanovsky Institute of Virology RAMS, Moscow, Russia; Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America; Department of Pathology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America","Conceived and designed the experiments: NAI RGW EAG. Performed the experiments: NAI JPS. Analyzed the data: NAI JER. Wrote the paper: NAI JER RGW EAG.","The authors declare no competing financial interests. While the study reported here did not utilize corporate funding, Drs. Natalia A. Ilyushina, Elena A. Govorkova, and Robert G. Webster are currently performing a different research study funded by F. Hoffmann-LaRoche, Ltd., Basel, Switzerland. In addition, the NA inhibitors oseltamivir carboxylate and zanamivir were provided by Hoffmann-La Roche, Ltd. (Basel, Switzerland).","2010","05","Natalia A Ilyushina","NAI",5,TRUE,3,2,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
